| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/08/1999 | CN1227873A Process for preparing recombination colibacillus periplasm protein liquid |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948933 Tropane analogs and methods for inhibition of monoamine transport |
| 09/07/1999 | US5948902 Antisense oligonucleotides to human serine/threonine protein phosphatase genes |
| 09/07/1999 | US5948898 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression |
| 09/07/1999 | US5948895 Process for producing a glycosylated amino compound |
| 09/07/1999 | US5948892 Analogs of macrophage stimulating protein |
| 09/07/1999 | US5948888 Neural thread protein gene expression and detection of Alzheimer's disease |
| 09/07/1999 | US5948887 Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site |
| 09/07/1999 | US5948886 Acylated enol derivatives of α-ketoesters and α-ketoamides |
| 09/07/1999 | US5948885 Mitogen-activated protein kinase p38-2 and methods of use therefor |
| 09/07/1999 | US5948884 Cyclic peptide with substituents on the methylene group of sarcosine in position 3 of cyclosporin; viricide against human immunodeficiency virus without immunosuppressive effect |
| 09/07/1999 | US5948883 Human CRM1 Protein |
| 09/07/1999 | US5948821 Methods of using ajoene |
| 09/07/1999 | US5948815 Using genistein |
| 09/07/1999 | US5948810 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
| 09/07/1999 | US5948799 Method for improving morbidity and/or mortality |
| 09/07/1999 | US5948790 Retroviral protease inhibitors |
| 09/07/1999 | US5948780 Administering a metalloproteinase inhibitor |
| 09/07/1999 | US5948778 Difluoro statone antiviral analogs |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948766 Use of tasteless, hydrolyzed collagen and agent containing the same |
| 09/07/1999 | US5948765 Inhibition of intracellular signal transduction by 14-3-3-binding peptides |
| 09/07/1999 | US5948764 Methods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic protein |
| 09/07/1999 | US5948763 Inhibitory peptide having a length of three to fifteen amino acids and comprising a portion of three to eight amino acids, which portion is hydrophobic and has one or more .beta.-sheet blocking amino acid residues therein |
| 09/07/1999 | US5948762 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor |
| 09/07/1999 | US5948761 For treating conditions characterized by high levels of extracellular fluid; human or veterinary medicine |
| 09/07/1999 | US5948760 Therapeutic use of superoxide dismutases |
| 09/07/1999 | US5948759 Factor VII fragment 82-128 and its use in blood-clotting disorders |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948757 High dose IGF-1 therapy |
| 09/07/1999 | US5948756 Therapeutic lipoprotein compositions |
| 09/07/1999 | US5948755 Cyclosporin compound, its preparation and the pharmaceutical compositions which contain it |
| 09/07/1999 | US5948754 Cyclic hexapeptides, their production and use |
| 09/07/1999 | US5948753 Cyclohexapeptidyl propanolamine compounds |
| 09/07/1999 | US5948752 Suppressory agents against hypercoagulation |
| 09/07/1999 | US5948751 X14-mannitol |
| 09/07/1999 | US5948750 Conjugates useful in the treatment of prostate cancer |
| 09/07/1999 | US5948749 Mixture of a divinylbenzene-styrene copolymer powder absorbent and biological active peptide |
| 09/07/1999 | US5948693 Solid phase synthesis of immunosuppressive agents |
| 09/07/1999 | US5948680 Antisense oligonucleotide targeted to nucleic acids encoding elk-1; antiproliferative agents |
| 09/07/1999 | US5948675 Host-vector system which can be used in gene therapy |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948664 Polypeptide for phosphatidyl inositol 3-kinase; for diagnosis and treatment of disorders caused by abnomalities in signal transduction such as growth factor activation cascade which leads to activation of ras oncogene; anticarcinogenic agents |
| 09/07/1999 | US5948658 Catalytic antibodies have unique potential for the treatment of cocaine addiction and overdose. |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948656 Proteins which bind to cytolytic lymphocyte cytoplasmic granule associated rna binding proteins; anticarcinogenic agents; treatment of graft vs. host disease, allograft rejection, transplantation organ rejections |
| 09/07/1999 | US5948647 Nucleic acids encoding antigen-binding sites specific for cancer antigens |
| 09/07/1999 | US5948644 Polynucleotides encoding excretory/secretory proteins of parasitic nematodes, host cells transformed therewith |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor |
| 09/07/1999 | US5948639 TGF-β pathway genes |
| 09/07/1999 | US5948638 TNF receptor death domain ligand proteins |
| 09/07/1999 | US5948637 Human and rat hypoxic stress proteins and DNAs encoding therefor |
| 09/07/1999 | US5948636 DNA and host cells encoding a cell surface protein of porphyromonas gingivalis |
| 09/07/1999 | US5948635 Totally Synthetic Affinity Reagents |
| 09/07/1999 | US5948634 Neural thread protein gene expression and detection of alzheimer's disease |
| 09/07/1999 | US5948626 Method of detecting human phospholipase inhibitor |
| 09/07/1999 | US5948625 Method of screening for ATP synthase Fo subunit |
| 09/07/1999 | US5948624 Methods for the detection and isolation of biomolecules |
| 09/07/1999 | US5948613 Methods of screening for risk of cancer using human lactoferrin DNA probe or primer |
| 09/07/1999 | US5948609 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 09/07/1999 | US5948442 Nucleoside, low and high molecular weight peptides, activation of biosynthesis of nucleic aics and specific proteins |
| 09/07/1999 | US5948432 Keratin-based sheet material for biomedical applications and method of production |
| 09/07/1999 | US5948428 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 09/07/1999 | US5948426 Method and article to induce hematopoietic expansion |
| 09/07/1999 | US5948412 Vaccine for Moraxella catarrhalis |
| 09/07/1999 | US5948409 T cell receptor ligands and methods of using same |
| 09/07/1999 | US5948408 DNA encoding bactericidal/permeability-increasing proteins |
| 09/07/1999 | US5948407 Oral induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/07/1999 | US5948403 Administering interferons |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | US5947708 Axial flow valve system for linear compressor |
| 09/07/1999 | CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same |
| 09/07/1999 | CA2128795C A virus-safe blood coagulation factor xiii preparation |
| 09/07/1999 | CA1340726C Redox amino acids and peptides containing them |
| 09/07/1999 | CA1340722C Pharmaceutical composition for the treatment of high blood pressure |
| 09/05/1999 | CA2264431A1 Canine factor viii gene, protein and methods of use |
| 09/02/1999 | WO1999043851A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | WO1999043842A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | WO1999043834A2 P-selectin ligand protein, including tetrameric fusion proteins |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043831A1 Cprot03, a human cysteine protease |
| 09/02/1999 | WO1999043829A2 Cell cycle related proteins |
| 09/02/1999 | WO1999043817A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | WO1999043816A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | WO1999043813A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | WO1999043808A1 Human c-maf compositions and methods of use thereof |
| 09/02/1999 | WO1999043807A2 Human channel-related molecules |
| 09/02/1999 | WO1999043806A1 Human smn-like protein |
| 09/02/1999 | WO1999043805A1 Human protein kinase c inhibitor |
| 09/02/1999 | WO1999043803A1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 09/02/1999 | WO1999043800A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72 |
| 09/02/1999 | WO1999043791A2 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 09/02/1999 | WO1999043785A1 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies |
| 09/02/1999 | WO1999043784A2 Novel compositions and methods for enhancing osseous growth, repair and regeneration |